Maze Therapeutics, Inc.
USD24.29
-1.17 (-4.60%)
CEO
Jason V. Coloma
IPO Date
2025-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$25.01
Prev. Close
$25.46
Day Low
$24.19
Day High
$25.36
52W Low
$9.83
52W High
$53.65
Market Cap
$1.34B
Volume
0.29M
| 2,478 |
| $26.00 |
| 27 May 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 25,582 | $26.02 |
| 18 May 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 1,822 | $26.00 |
| 18 May 2026 | Coloma Jason V | director, officer: Chief Executive Officer | S-Sale | Disposed | 116 | $26.00 |
| 18 May 2026 | Bernstein Harold | President, R&D & CMO | M-Exempt | Acquired | 15,000 | $10.42 |
| 18 May 2026 | Bernstein Harold | President, R&D & CMO | S-Sale | Disposed | 15,000 | $26.22 |
| 18 May 2026 | Bernstein Harold | President, R&D & CMO | M-Exempt | Disposed | 15,000 | $10.42 |
| 6 May 2026 | Dandekar Atul | CSBO | M-Exempt | Acquired | 8,320 | $10.42 |
| 6 May 2026 | Dandekar Atul | CSBO | M-Exempt | Acquired | 5,985 | $10.42 |